Median Technologies

Median Technologies awarded Futur40 Prize by Forbes France

Wednesday, July 19, 2017

Median Technologies, the Imaging Phenomics Company, announced that on it was awarded the Futur40 Prize by Forbes France, in association with PME finance – Europe Entrepreneurs, the French Finance Association Paris Europlace and the Federation of Individual Investors and the Finance Clubs (F2iC – Fédération des Investisseurs Individuels et des Clubs d’investissement).

[Read More]

Median Technologies, Medidata partner on image management services

Tuesday, June 27, 2017

Medidata, a global provider of cloud-based solutions and data analytics for clinical research, and Median Technologies, the Imaging Phenomics Company, announced a new collaboration to streamline the growth and use of medical imaging in cancer clinical trials. Median Technologies will leverage the Medidata Clinical Cloud to accelerate the development of medicines in oncology with new, scalable image management services.

[Read More]

Median Technologies, inVentiv Health partner on medical image analysis

Wednesday, April 12, 2017

Median Technologies, an Imaging Phenomics Company, and inVentiv Health, a biopharmaceutical professional services company, have announced a strategic alliance to offer biopharmaceutical clients with best-in-class medical image analysis and management services for early- to late-stage oncology clinical trials. The alliance will provide inVentiv clients with the most advanced imaging biomarkers, at a time when 73% of cancer compounds in clinical trials involve biomarkers in their research and development design.

[Read More]